AstraZeneca continues to impress me with the strong performances of its oncology, cardiovascular, and rare disease franchises ...

High-end medical devices, including those made in the United States, may be especially vulnerable to tariffs because they’re ...

The challenges and opportunities about writing on investing for the first time? Read more on one analyst's experience.

First, eligible companies must hold or intend to apply for a Good Manufacturing Practice (GMP) Human Medicines license or an Investigational Medicinal Products Directive (IMPD) license.

Aurinia Pharma and partner Otsuka have secured approval in the EU for Lupkynis, billed as the first oral treatment for active nephritis in patients with the autoimmune disease systemic lupus ...

Master artificial intelligence in 2025. Complete guide covering AI fundamentals, machine learning, deep learning, and ...